Ignite Creation Date:
2025-12-24 @ 3:36 PM
Ignite Modification Date:
2026-03-06 @ 8:54 AM
Study NCT ID:
NCT02926092
Status:
TERMINATED
Last Update Posted:
2021-03-17
First Post:
2016-10-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Observational Natural History Study of Autosomal Dominant Retinitis Pigmentosa (adRP)
Sponsor:
Shire
Organization:
Study Overview
Official Title:
A Prospective, Multicenter, Longitudinal, Observational Natural History Study to Evaluate Disease Progression in Subjects With Autosomal Dominant Retinitis Pigmentosa (adRP) With Misfolded Rod Opsin Mutations
Status:
TERMINATED
Status Verified Date:
2021-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Development of SHP630 was discontinued based on lack of preclinical efficacy.
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to gain an understanding of how adRP progresses over time in patients with misfolded rod opsin mutations.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: